🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 10 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/06/2017 | 69,80 | 70,37 | 68,84 | 69,86 | +0,42% | 2,19% | 211.756 |
| 02/06/2017 | 68,28 | 69,73 | 68,00 | 69,57 | +1,23% | 2,53% | 262.571 |
| 01/06/2017 | 67,77 | 69,08 | 67,16 | 68,73 | +1,75% | 2,84% | 419.345 |
| 31/05/2017 | 68,32 | 68,55 | 67,22 | 67,55 | -0,82% | 1,94% | 575.317 |
| 30/05/2017 | 68,62 | 69,14 | 68,02 | 68,11 | -0,92% | 1,64% | 324.928 |
| 26/05/2017 | 70,50 | 70,62 | 68,39 | 68,74 | -2,92% | 3,17% | 349.294 |
| 25/05/2017 | 71,13 | 71,52 | 70,36 | 70,80 | +0,11% | 1,63% | 258.564 |
| 24/05/2017 | 71,01 | 71,65 | 70,68 | 70,73 | -0,39% | 1,37% | 276.678 |
| 23/05/2017 | 71,00 | 71,55 | 70,38 | 71,00 | +0,34% | 1,65% | 175.849 |
| 22/05/2017 | 71,02 | 71,40 | 70,26 | 70,77 | -0,33% | 1,62% | 264.655 |
| 19/05/2017 | 70,99 | 71,61 | 70,82 | 71,00 | -0,09% | 1,11% | 248.625 |
| 18/05/2017 | 70,87 | 71,72 | 70,49 | 71,06 | +0,52% | 1,73% | 237.084 |
| 17/05/2017 | 70,86 | 71,29 | 70,47 | 70,69 | -1,16% | 1,16% | 364.362 |
| 16/05/2017 | 71,30 | 71,68 | 70,26 | 71,52 | +0,51% | 1,99% | 316.753 |
| 15/05/2017 | 70,62 | 71,43 | 70,51 | 71,16 | +0,99% | 1,30% | 252.312 |
| 12/05/2017 | 68,80 | 70,48 | 68,68 | 70,46 | +2,07% | 2,61% | 411.009 |
| 11/05/2017 | 68,28 | 69,36 | 67,44 | 69,03 | +1,14% | 2,82% | 298.158 |
| 10/05/2017 | 65,91 | 71,93 | 65,03 | 68,25 | -4,97% | 10,46% | 683.680 |
| 09/05/2017 | 70,06 | 72,06 | 69,66 | 71,82 | +2,15% | 3,43% | 458.779 |
| 08/05/2017 | 70,21 | 71,50 | 69,80 | 70,31 | -0,03% | 2,43% | 393.537 |
| 05/05/2017 | 70,51 | 70,69 | 69,50 | 70,33 | -0,35% | 1,69% | 205.505 |
| 04/05/2017 | 69,73 | 70,94 | 69,20 | 70,58 | +1,26% | 2,49% | 235.000 |
| 03/05/2017 | 70,49 | 70,61 | 69,50 | 69,70 | -1,29% | 1,58% | 197.810 |
| 02/05/2017 | 71,00 | 71,13 | 69,36 | 70,61 | -0,50% | 2,49% | 311.944 |
| 01/05/2017 | 69,46 | 71,02 | 69,38 | 70,97 | +2,33% | 2,37% | 369.011 |
| 28/04/2017 | 69,36 | 69,81 | 68,90 | 69,35 | -0,02% | 1,30% | 232.435 |
| 27/04/2017 | 68,47 | 69,78 | 68,01 | 69,36 | +1,63% | 2,58% | 272.029 |
| 26/04/2017 | 68,00 | 69,06 | 67,07 | 68,25 | +0,47% | 2,93% | 415.658 |
| 25/04/2017 | 66,08 | 68,40 | 66,05 | 67,94 | +3,60% | 3,56% | 385.041 |
| 24/04/2017 | 65,81 | 66,12 | 65,10 | 65,58 | +0,70% | 1,55% | 208.069 |